EE05231B1 - Tramadoolvesinikkloriidi sisaldav toimeainet reguleeritult vabastav ravimkoostis ja meetod selle valmistamiseks - Google Patents

Tramadoolvesinikkloriidi sisaldav toimeainet reguleeritult vabastav ravimkoostis ja meetod selle valmistamiseks

Info

Publication number
EE05231B1
EE05231B1 EEP200200368A EEP200200368A EE05231B1 EE 05231 B1 EE05231 B1 EE 05231B1 EE P200200368 A EEP200200368 A EE P200200368A EE P200200368 A EEP200200368 A EE P200200368A EE 05231 B1 EE05231 B1 EE 05231B1
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
controlled release
release pharmaceutical
tramadol hydrochloride
Prior art date
Application number
EEP200200368A
Other languages
English (en)
Estonian (et)
Inventor
R βzus L'uboslav
Sedl βrov β Helena
Varga Ivan
Gattnar Ondrej
βn Zem βnek Mari
Original Assignee
Slovakofarma A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma A.S. filed Critical Slovakofarma A.S.
Publication of EE200200368A publication Critical patent/EE200200368A/xx
Publication of EE05231B1 publication Critical patent/EE05231B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200200368A 1999-12-28 2000-12-20 Tramadoolvesinikkloriidi sisaldav toimeainet reguleeritult vabastav ravimkoostis ja meetod selle valmistamiseks EE05231B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK1868-99A SK285128B6 (sk) 1999-12-28 1999-12-28 Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy
PCT/SK2000/000027 WO2001047497A2 (en) 1999-12-28 2000-12-20 Controlled release pharmaceutical composition containing tramadol hydrochloride

Publications (2)

Publication Number Publication Date
EE200200368A EE200200368A (et) 2003-10-15
EE05231B1 true EE05231B1 (et) 2009-12-15

Family

ID=20434830

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200368A EE05231B1 (et) 1999-12-28 2000-12-20 Tramadoolvesinikkloriidi sisaldav toimeainet reguleeritult vabastav ravimkoostis ja meetod selle valmistamiseks

Country Status (25)

Country Link
US (1) US20030175343A1 (pt)
EP (1) EP1255535B1 (pt)
JP (1) JP2003518486A (pt)
AT (1) ATE324103T1 (pt)
AU (1) AU2421601A (pt)
BG (1) BG65713B1 (pt)
CA (1) CA2397942C (pt)
CY (1) CY1106127T1 (pt)
CZ (1) CZ297394B6 (pt)
DE (1) DE60027601T2 (pt)
DK (1) DK1255535T3 (pt)
EA (1) EA006438B1 (pt)
EE (1) EE05231B1 (pt)
ES (1) ES2266018T3 (pt)
GE (1) GEP20053532B (pt)
HU (1) HUP0203842A3 (pt)
LT (1) LT5033B (pt)
LV (1) LV12917B (pt)
PL (1) PL208096B1 (pt)
PT (1) PT1255535E (pt)
SI (1) SI1255535T1 (pt)
SK (1) SK285128B6 (pt)
TW (1) TWI221419B (pt)
UA (1) UA76411C2 (pt)
WO (1) WO2001047497A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
SK286107B6 (sk) * 2002-04-12 2008-03-05 Zentiva, A. S. Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
DE10245623A1 (de) * 2002-09-30 2004-04-08 Clariant Gmbh Ester und Partialester aus mehrwertigen Alkoholen
EP1651248B1 (en) * 2003-07-11 2009-09-09 Novartis AG Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
US20100143573A1 (en) * 2006-06-09 2010-06-10 John Godber Mineral fortification substance for clear beverages
BRPI0712181A2 (pt) * 2006-06-09 2012-01-17 Innophos Inc substáncia de fortificação com cálcio para bebidas claras
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
EP0654263B1 (en) 1993-11-23 2002-01-23 Euro-Celtique S.A. Method for preparing a sustained release composition
DE4343993A1 (de) * 1993-12-22 1995-06-29 Stockhausen Chem Fab Gmbh Pfropf-Copolymerisate von ungesättigten Monomeren und Polyhydroxyverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0203842A3 (en) 2004-06-28
EA006438B1 (ru) 2005-12-29
UA76411C2 (en) 2006-08-15
SI1255535T1 (sl) 2006-10-31
SK186899A3 (en) 2001-07-10
DE60027601T2 (de) 2007-04-26
CY1106127T1 (el) 2011-06-08
US20030175343A1 (en) 2003-09-18
SK285128B6 (sk) 2006-07-07
CZ20022371A3 (cs) 2002-10-16
CA2397942C (en) 2008-07-15
DK1255535T3 (da) 2006-08-28
GEP20053532B (en) 2005-05-25
BG65713B1 (bg) 2009-08-31
EP1255535A2 (en) 2002-11-13
LV12917B (en) 2003-02-20
EP1255535B1 (en) 2006-04-26
AU2421601A (en) 2001-07-09
LT5033B (lt) 2003-07-25
ATE324103T1 (de) 2006-05-15
DE60027601D1 (de) 2006-06-01
CA2397942A1 (en) 2001-07-05
EA200200720A1 (ru) 2003-02-27
JP2003518486A (ja) 2003-06-10
CZ297394B6 (cs) 2006-12-13
WO2001047497A2 (en) 2001-07-05
LT2002078A (en) 2003-03-25
TWI221419B (en) 2004-10-01
PL208096B1 (pl) 2011-03-31
WO2001047497A3 (en) 2002-09-12
EE200200368A (et) 2003-10-15
HUP0203842A2 (hu) 2003-05-28
ES2266018T3 (es) 2007-03-01
BG106952A (en) 2003-03-31
PL357680A1 (en) 2004-07-26
PT1255535E (pt) 2006-09-29

Similar Documents

Publication Publication Date Title
CY1106127T1 (el) Φαρμακευτικη συσταση ελεγχομενης αποδεσμευσης που πepιεχει υδροχλωρικη τραμαδολη
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
UY27320A1 (es) Nuevas composiciones farmacéuticas
HUP0201444A2 (hu) Hosszú láncú triglicerideket és lipofil, felületaktív anyagokat tartalmazó orális adagolású gyógyszerkészítmények
AU3708599A (en) Use of pharmaceutical compositions capable of being gelled in periodontology
ATE429416T1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
MY151470A (en) Controlled release solid preparation
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
HUP0204513A3 (en) Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients
CY1115401T1 (el) Συνθεσεις για χορηγηση απο του στοματος δραστικων ενωσεων που απαιτουν συγκαλυψη της γευσης
MY138975A (en) Novel preparation and administration form comprising an acid-labile active compound
CO5170438A1 (es) Proceso para la preparacion de un comprimido de betahistina de liberacion controlada por granulacion en estado fundido y comprimido de liberacion controlada de betahistina obtenido mediante dicho proceso
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
WO2003013441A3 (en) Levothyroxine compositions and methods
WO2006064321A3 (en) Controlled release compositions of divalproex sodium
WO2006011001A3 (en) Controlled release compositions of divalproex sodium
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény

Legal Events

Date Code Title Description
HC1A Change of owner name
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231